SCHEMBL16649604

SCHEMBL16649604

NC(=O)C(CCc1ccccc1)N1CCN(c2nc(N)nc3sc(CCc4ccc(F)cc4)nc23)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KB Q9UBF8 9/20 0.39
KCNH2 Q12809 3/20 0.39
HRH4 Q9H3N8 1/20 0.34
GFER P55789 1/20 0.34
PANK3 Q9H999 1/20 0.34
RAB9A P51151 1/20 0.33
CYP3A4 P08684 2/20 0.33
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
THRB P10828 1/20 0.33
PTGS2 P35354 1/20 0.33
HTR7 P34969 1/20 0.33
RAD52 P43351 1/20 0.32
KIT P10721 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653832 0.83 GFER (0.53) PI4KBKCNH2GFERPANK3MAPT
SCHEMBL654037 0.80 GBA1 (0.42) PI4KBKCNH2PTGS2GAA
SCHEMBL652417 0.80 DRD4 (0.43) PI4KBKCNH2RAB9ACYP3A4MAPT
SCHEMBL653262 0.80 MEN1 (0.50) PI4KBKCNH2GFERRAB9ALMNA
SCHEMBL653656 0.79 HTR2A (0.44) CYP3A4HTR7KDM4E
SCHEMBL655387 0.79 PI4KB (0.53) PI4KBKCNH2MAPTLMNAKDM4E
SCHEMBL654836 0.77 HRH4 (0.45) KCNH2HRH4
SCHEMBL1720346 0.76 KMT2A (0.45) PI4KBKCNH2GFERPANK3MAPT
SCHEMBL656147 0.76 LTA4H (0.42) PI4KBKCNH2HTR7
SCHEMBL651832 0.76 HSP90AA1 (0.47) PI4KBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2616077-B1 ANTI-CANCER ACTIVITY OF NOVEL BICYCLIC HETEROCYCLES UNIV LEUVEN KATH (BE) 2016-08-31 EP claimed
EP-2405973-B1 THIAZOLOPYRIMIDINE MODULATORS AS IMMUNOSUPPRESSIVE AGENTS UNIV LEUVEN KATH (BE) 2015-04-22 EP claimed